Emblaveo (aztreonam/avibactam) - Pfizer, AbbVie
Fetroja (cefiderocol) - Shionogi
Blujepa (gepotidacin) - GSK
Zevtera (ceftobiprole) - Basilea
Emrok (levonadifloxacin) - Wockhardt
Zemdri (plazomicin) - Ionis, Achaogen
Exblifep (cefepime/enmetazobactam) - Allecra
Xacduro (sulbactam-durlobactam) - Innoviva
Recarbrio (relebactam/imepenem/cilastatin) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/40711050
 
Charalampos Loutradis; Laura T Romanos; Matthew E Falagas; Panagiotis Stathopoulos
 
Jul 25, 2025
 
Prev Next